Sold Out
Book Categories |
List of contributors | ||
Preface | ||
Acknowledgments | ||
1 | Zinc toxicity in the ischemic brain | 3 |
2 | Central nervous system ischemia: diversity among the caspases | 9 |
3 | Peroxynitrite and injury to the vasculature and central nervous system in stroke and neurodegeneration | 23 |
4 | Interaction between inducible nitric oxide and cyclooxygenase-2 in ischemic brain injury | 47 |
5 | Mechanisms of ischemic tolerance | 58 |
6 | Clinically tolerated NMDA receptor antagonists and newly cloned NMDA receptor subunits that mimic them | 72 |
7 | Cell death programs in neural development and disease | 81 |
8 | Apoptotic gene expression in brain ischemia and ischemic tolerance | 87 |
9 | Cellular mechanisms of white matter ischemia: what can we learn from culture models? | 95 |
10 | Astrocytes in ischemic stroke | 113 |
11 | Aquaporin-4 water channels and brain edema | 125 |
12 | Neuroprotection with tetracyclines in brain ischemia models | 135 |
13 | Spreading depression: a teleological means for self-protection from brain ischemia | 142 |
14 | The role of matrix metalloproteinases and urokinase in blood-brain barrier damage with thrombolysis | 161 |
15 | Does brain nitric oxide generation influence tissue oxygenation after severe human subarachnoid hemorrhage? | 172 |
16 | Tissue plasminogen activator and hemorrhagic brain injury | 181 |
17 | Dynamics of infarct evolution after permanent and transient focal brain ischemia in mice | 192 |
18 | Inflammation and stroke: benefits or harm? | 213 |
19 | TNF-[alpha] and ceramide are involved in the mediation of neuronal tolerance to brain ischemia | 226 |
20 | Sites and mechanisms of IL-1 action in ischemic and excitotoxic brain damage | 237 |
21 | Protease generation, inflammation and cerebral microvascular activation | 247 |
22 | Adenoviral vectors for gene therapy in stroke | 261 |
23 | Gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury | 269 |
24 | Vasomotor effects of nitric oxide, superoxide dismutases and calcitonin gene-related peptide | 284 |
25 | Transplantation of neural stem cells: cellular and gene therapy in pediatric hypoxic-ischemic brain injury | 299 |
26 | Neural plasticity after cerebral ischemia | 317 |
27 | Environmental effects on recovery after stroke | 328 |
28 | Magnetic resonance imaging in stroke trials | 339 |
29 | Disappearing deficits and disappearing lesions: diffusion/perfusion MRI in transient ischemic attack and intra-arterial thrombolysis | 353 |
30 | Diffusion and perfusion magnetic resonance imaging in the evaluation of acute ischemic stroke | 371 |
31 | Early recanalization in acute ischemic stroke saves tissue at risk defined by stroke magnetic resonance imaging | 381 |
32 | Vascular factors in Alzheimer's disease | 393 |
33 | Beyond neuroprotection: the protection of axons and oligodendrocytes in cerebral ischemia | 404 |
34 | Combining neuroprotection with thrombolysis: how to translate laboratory success to our clinical trials | 416 |
35 | Prospects for improved neuroprotection trials in stroke | 430 |
36 | Basic research and stroke therapeutics: what have we learned? | 444 |
Index | 452 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionCerebrovascular Disease: 22nd Princeton Conference
X
This Item is in Your InventoryCerebrovascular Disease: 22nd Princeton Conference
X
You must be logged in to review the productsX
X
X
Add Cerebrovascular Disease: 22nd Princeton Conference, , Cerebrovascular Disease: 22nd Princeton Conference to the inventory that you are selling on WonderClubX
X
Add Cerebrovascular Disease: 22nd Princeton Conference, , Cerebrovascular Disease: 22nd Princeton Conference to your collection on WonderClub |